Evidence map›Paper›PMID 30735632›Full record

ArticleCell2019

Small-Molecule Agonists of Ae. aegypti Neuropeptide Y Receptor Block Mosquito Biting.

Laura B Duvall, Lavoisier Ramos-Espiritu, Kyrollos E Barsoum, J Fraser Glickman, Leslie B Vosshall

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 119 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. A single-nucleus transcriptomic atlas of the adultbioRxiv : the preprint server for biology · 2025
    Article
  14. Article
  15. Post-biting behavioral reprogramming underlies reproductive efficiency inbioRxiv : the preprint server for biology · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Laura B DuvallLaboratory of Neurogenetics and Behavior, The Rockefeller University, New York, NY 10065, USA.
Lavoisier Ramos-EspirituHigh-Throughput Screening and Spectroscopy Resource Center, The Rockefeller University, New York, NY 10065, USA.
Kyrollos E BarsoumLaboratory of Neurogenetics and Behavior, The Rockefeller University, New York, NY 10065, USA.
J Fraser GlickmanHigh-Throughput Screening and Spectroscopy Resource Center, The Rockefeller University, New York, NY 10065, USA.
Leslie B VosshallLaboratory of Neurogenetics and Behavior, The Rockefeller University, New York, NY 10065, USA; Howard Hughes Medical Institute, New York, NY 10065, USA; Kavli Neural Systems Institute, New York, NY 10065, USA. Electronic address: leslie.vosshall@rockefeller.edu.
Rockefeller University · USNeural Stem Cell Institute · US

Funding

Transforming Translational Science and Education to Benefit Human HealthUL1TR000043 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY · 2012 to 2015
$26.8M
Neuropeptide Regulation of Mosquito Host-Seeking BehaviorR01DC014247 · NIDCD · ROCKEFELLER UNIVERSITY · PI VOSSHALL, LESLIE B · 2015 to 2019
$1.8M
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR000043NIDCD NIH HHS R01 DC014247
6 · The paper itself

Abstract

Female Aedes aegypti mosquitoes bite humans to obtain blood to develop their eggs. Remarkably, their strong attraction to humans is suppressed for days after the blood meal by an unknown mechanism. We investigated a role for neuropeptide Y (NPY)-related signaling in long-term behavioral suppression and discovered that drugs targeting human NPY receptors modulate mosquito host-seeking. In a screen of all 49 predicted Ae. aegypti peptide receptors, we identified NPY-like receptor 7 (NPYLR7) as the sole target of these drugs. To obtain small-molecule agonists selective for NPYLR7, we performed a high-throughput cell-based assay of 265,211 compounds and isolated six highly selective NPYLR7 agonists that inhibit mosquito attraction to humans. NPYLR7 CRISPR-Cas9 null mutants are defective in behavioral suppression and resistant to these drugs. Finally, we show that these drugs can inhibit biting and blood-feeding on a live host, suggesting a novel approach to control infectious disease transmission by controlling mosquito behavior. VIDEO ABSTRACT.

Indexed as

AedesAnimalsFeeding BehaviorFemaleHEK293 CellsHost-Seeking BehaviorHumansInsect Bites and StingsMosquito VectorsReceptors, Neuropeptide YSmall Molecule LibrariesReceptors, Neuropeptide YSmall Molecule LibrariesAedes aegyptiblood-feedingCRISPR-Cas9denguefeedinghigh-throughput small-molecule screenhost-seeking behaviormosquitoneuropeptide YZika

Identifiers

PMID30735632
PMCPMC6369589
OpenAlexW2912505923

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.